D-dopa

Revision as of 13:24, 4 May 2009 by Dkhabbaz (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:OrganicBox small

WikiDoc Resources for D-dopa

Articles

Most recent articles on D-dopa

Most cited articles on D-dopa

Review articles on D-dopa

Articles on D-dopa in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on D-dopa

Images of D-dopa

Photos of D-dopa

Podcasts & MP3s on D-dopa

Videos on D-dopa

Evidence Based Medicine

Cochrane Collaboration on D-dopa

Bandolier on D-dopa

TRIP on D-dopa

Clinical Trials

Ongoing Trials on D-dopa at Clinical Trials.gov

Trial results on D-dopa

Clinical Trials on D-dopa at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on D-dopa

NICE Guidance on D-dopa

NHS PRODIGY Guidance

FDA on D-dopa

CDC on D-dopa

Books

Books on D-dopa

News

D-dopa in the news

Be alerted to news on D-dopa

News trends on D-dopa

Commentary

Blogs on D-dopa

Definitions

Definitions of D-dopa

Patient Resources / Community

Patient resources on D-dopa

Discussion groups on D-dopa

Patient Handouts on D-dopa

Directions to Hospitals Treating D-dopa

Risk calculators and risk factors for D-dopa

Healthcare Provider Resources

Symptoms of D-dopa

Causes & Risk Factors for D-dopa

Diagnostic studies for D-dopa

Treatment of D-dopa

Continuing Medical Education (CME)

CME Programs on D-dopa

International

D-dopa en Espanol

D-dopa en Francais

Business

D-dopa in the Marketplace

Patents on D-dopa

Experimental / Informatics

List of terms related to D-dopa

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

D-DOPA (Dextrodopa) is similar to L-DOPA (levodopa, 3,4-dihydroxy-L-phenylalanine), but differs in its property of dextrorotation. Levo- and dextro- rotation reference a molecules ability to rotate planes of polarized light in either direction.

While L-Dopa is moderately effective against the loss of natural dopamine in Parkinson's disease, D-Dopa is biologically inactive. D- dopa is L- Dopa's enantiomer. See L-DOPA for more information about DOPA in general.



Template:SIB



Template:WikiDoc Sources